BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
December 06, 2023 14:20 ET
|
BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 13, 2023 16:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 09, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Westport, CT, Nov. 9, 2023 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to...
Electrophysiology Devices Global Strategic Business Report: Players Include CardioFocus, Medtronic, MicroPort Scientific and Nihon Kohden
November 07, 2023 07:23 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Electrophysiology Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Thyroid Ablation Devices Market to Reach $318.4 Million by 2030: Growing Preference for Minimally Invasive Surgeries Drives the Sector
November 03, 2023 07:03 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Thyroid Ablation Devices Market Size, Share & Trends Analysis Report By Product (Non-thermal, Thermal), By Application (Cancer, Nodules), By...
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
November 02, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI
November 01, 2023 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
Global Cardiac Ablation Device Market Set for Remarkable Growth, Fueled by Rising Demand for Minimally Invasive Procedures and Technological Advancements
October 30, 2023 08:13 ET
|
Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Cardiac Ablation Devices Market" report has been added to ResearchAndMarkets.com's offering. Rising incidents of cardiac arrhythmia and the...
Disposable Radiofrequency Ablation Devices Lead Market Growth, Enhancing Safety and Efficiency in Healthcare Procedures
October 13, 2023 06:43 ET
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "Radiofrequency Ablation Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity...
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
August 24, 2023 10:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...